Novartis Investigative Site is a clinical research site located in Tyler, Texas, United States 75701.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 13 clinical trials.
Therapeutic areas: Age-Related Macular Degeneration, Leukaemia, Lymphocytic, Chronic, Carcinoma, Renal Cell.
Sponsors: Novartis Pharmaceuticals, Mylan Inc..
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 13 clinical trials on record. Their work covers Age-Related Macular Degeneration, Leukaemia, Lymphocytic, Chronic, Carcinoma, Renal Cell.
Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.